A widely representative World Health Organization technical working group has recommended new terminology for substandard or falsified medicines, after years of sharp disagreement among WHO members that led to the tongue-twister: “substandard/spurious/falsely-labelled/falsified/counterfeit” medical products. The working group recommends a simpler formula: kick out intellectual property rights by dropping the term “counterfeit” and just call the products “substandard and falsified.”
